Pathstone Family Office’s Neurotrope, Inc. Common NTRP Stock Holding History

Pathstone Family Office’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,694	Closed	-$102K	–	727
2019 Q2	$102K	Sell	12,694 -17,952	-59%	-$121K	0.01%	255
2019 Q1	$167K	Hold	30,646	–	–	0.02%	185
2018 Q4	$109K	Hold	30,646	–	–	0.03%	126
2018 Q3	$270K	Buy	+30,646	New	+$293K	0.08%	52
2018 Q2	–	Sell	-30,646	Closed	-$249K	–	360
2018 Q1	$249K	Hold	30,646	–	–	0.14%	47
2017 Q4	$216K	Hold	30,646	–	–	0.12%	32
2017 Q3	$158K	Hold	30,646	–	–	0.14%	42
2017 Q2	$287K	Hold	30,646	–	–	0.12%	77
2017 Q1	$586K	Buy	+30,646	New	+$580K	0.32%	34

Other funds holding NTRP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pathstone Family Office's NTRP Position: Q3 2019 in Review

Pathstone Family Office sold out of Neurotrope, Inc. Common (NTRP) in Q3 2019, closing a stake of 12,694 shares — an estimated $102K sold.

Pathstone Family Office first reported a position in NTRP in Q1 2017 and held it in 9 quarters. The position peaked at $586K in Q1 2017. 29 funds tracked by Wall St. Rank hold NTRP as of Q3 2019.

Pathstone Family Office reported no remaining Neurotrope, Inc. Common position as of Q3 2019 after selling out during the quarter.
Pathstone Family Office sold 12,694 Neurotrope, Inc. Common shares in Q3 2019, an estimated $102K.
Pathstone Family Office first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 9 quarters.
Pathstone Family Office's Neurotrope, Inc. Common position peaked at $586K in Q1 2017.
29 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2019.

Based on Pathstone Family Office's 13F filing for Q3 2019, filed 13 Nov 2019.